Description:
The CONTAK RENEWAL 3&4 FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES by Boston Scientific Corp. are advanced cardiovascular treatment units designed to ease the symptoms of heart failure and significantly improve patients' quality of life. These devices work by resynchronizing the heartbeat, helping the heart’s chambers to beat simultaneously, therefore optimizing cardiac performance.
The CONTAK RENEWAL 3&4 devices offer a significant benefit over conventional heart failure treatment devices. They incorporate advanced technology that enables more personalized treatment, ensuring the therapy precisely meets the distinct needs of each individual.
The devices are equipped with multisite pacing and are designed to efficiently monitor heart activity, providing constant and effective therapy. They are also compatible with diagnostics, delivering an intelligible assessment of the patient’s heart palpitations and episodes. Notably, these devices are telemetry-enabled for remote monitoring, making follow-up appointments and care more convenient for both medical professionals and patients.
By improving heart function and limiting hospital admissions, the CONTAK RENEWAL 3&4 devices not only enhance the patient's health status, but they also substantially improve the patient's overall quality of life.